Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats
- PMID: 34028896
- DOI: 10.1111/fcp.12691
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats
Comment on
-
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats.Fundam Clin Pharmacol. 2021 Aug;35(4):669-680. doi: 10.1111/fcp.12599. Epub 2020 Sep 10. Fundam Clin Pharmacol. 2021. PMID: 32810901
References
REFERENCES
-
- Wils J, Djerada Z, Roca F et al. Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging. Atherosclerosis. 2018;275:239-245.
-
- Hamzaoui M, Djerada Z, Brunel V et al. 5/6 nephrectomy induces different renal, cardiac and vascular consequences in 129/Sv and C57BL/6JRj mice. Sci Rep. 2020;10:1524.
-
- Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014;66:1142-1174.
-
- Hausenloy DJ, Botker HE, Engstrom T et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2017;38:935-941.
-
- Tigerstedt R, Bergman PQ. Niere und Kreislauf1. Skand Arch Für Physiol. 1898;8:223-271.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
